1. EXPRESSION OF VASCULOENDOTHELIAL AND PLATE GROWTH FACTORS IN PRIMARY COLORECTAL TUMOR AS A PREDICTOR OF EARLY RECURRENCE
   I.A. Bogomolova et al, 2020, Ulyanovsk Medico-biological Journal CrossRef
2. Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC
   Daniela Bianconi et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
3. TGF-β/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer
   Letizia Scola et al, 2022, Genes CrossRef
4. Interrogating the interplay of angiogenesis and immunity in metastatic colorectal cancer
   Katerina Kampoli et al, 2022, World Journal of Methodology CrossRef
5. Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer
   Shuyan Yang et al, 2022, Journal of Immunology Research CrossRef
6. “Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer
   Adriano Angelucci et al, 2018, International Journal of Molecular Sciences CrossRef
7. Lymph microvascularization as a prognostic indicator in neuroblastoma
   Irene Tadeo et al, 2018, Oncotarget CrossRef
8. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
   Roberto Dinami et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
9. HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1
   Ye Huang et al, 2021, Cell Cycle CrossRef